Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma. (Q47093592)
Jump to navigation
Jump to search
scientific article published on 3 August 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma. |
scientific article published on 3 August 2017 |
Statements
1 reference
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma. (English)
1 reference
Amalia De Renzo
Vittorio Stefoni
Alessandro Broccoli
Alice Di Rocco
Benedetta Puccini
Caterina Patti
Guido Gini
Donato Mannina
Monica Tani
Chiara Rusconi
Alessandra Romano
Anna Vanazzi
Barbara Botto
Stefan Hohaus
Pellegrino Musto
Patrizio Mazza
Stefano Molica
Paolo Corradini
Angelo Fama
Angela Gravetti
Annalisa Arcari
Patrizia Tosi
Anna Marina Liberati
Antonello Pinto
Vincenzo Pavone
Filippo Gherlinzoni
Virginia Naso
Stefano Volpetti
Maria Cecilia Goldaniga
Corrado Schiavotto
Sergio Storti
Angelo Michele Carella
3 August 2017
1 reference